Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Wasan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|March 13, 1999
Effect of flutamide on survival in patients with pancreatic cancer. No recommendations can be madeH S Wasan
Lancet (London, England)|January 16, 1993
Clodronate for multiple myelomaH S Wasan, J Waxman
Clinical Endocrinology|December 1, 1992
Hormonal management of prostate cancerH S Wasan, J Waxman
Lancet (London, England)|August 3, 1996
Fibre-supplemented foods may damage your healthH S Wasan, R A Goodlad
British Journal of Urology|March 1, 1995
Failure of normalization of alphafetoprotein levels following the successful treatment of teratoma: a diagnostic trap for the unwaryH S Pandha, H S Wasan, J Waxman
BMJ (Clinical Research Ed.)|August 12, 1995
Failure of normalisation of alpha fetoprotein concentration after successful treatment of teratomaH S Pandha, H S Wasan, K Harrington, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Dietary fat influences on polyp phenotype in multiple intestinal neoplasia miceH S Wasan, M Novelli, J Bee, et al.
Cancer|February 1, 1994
Combined choriocarcinoma and yolk sac tumor arising in Barrett's esophagusH S Wasan, J B Schofield, T Krausz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 29, 2008
FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancerR A Sharma, H S Wasan, S B Love, et al.
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|March 13, 1999
Effect of flutamide on survival in patients with pancreatic cancer. No recommendations can be madeH S Wasan
Lancet (London, England)|January 16, 1993
Clodronate for multiple myelomaH S Wasan, J Waxman
Clinical Endocrinology|December 1, 1992
Hormonal management of prostate cancerH S Wasan, J Waxman
Lancet (London, England)|August 3, 1996
Fibre-supplemented foods may damage your healthH S Wasan, R A Goodlad
British Journal of Urology|March 1, 1995
Failure of normalization of alphafetoprotein levels following the successful treatment of teratoma: a diagnostic trap for the unwaryH S Pandha, H S Wasan, J Waxman
BMJ (Clinical Research Ed.)|August 12, 1995
Failure of normalisation of alpha fetoprotein concentration after successful treatment of teratomaH S Pandha, H S Wasan, K Harrington, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Dietary fat influences on polyp phenotype in multiple intestinal neoplasia miceH S Wasan, M Novelli, J Bee, et al.
Cancer|February 1, 1994
Combined choriocarcinoma and yolk sac tumor arising in Barrett's esophagusH S Wasan, J B Schofield, T Krausz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 29, 2008
FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancerR A Sharma, H S Wasan, S B Love, et al.
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Pageof 2